From: The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial
Construct | Measure | Clinically relevant change |
---|---|---|
Primary Outcome | ||
Exercise capacity | V02peak | |
Components of Global Outcome | ||
Exercise efficiency: Gross, net and work efficiency | Gross efficiency = work performed / energy expended × 100%, Net efficiency = work performed / energy expended above rest × 100%, and Work efficiency = work performed / energy expended above that in cycling at 0 W × 100% [57]. | 10% change [58]. |
Sub-maximal exercise capacity | The Modified Canadian Aerobic Fitness Test (mCAFT) is a multi-stage step-test, simple to use and inexpensive, that assesses sub-maximal aerobic capacity [59]. | 1 stage [59] |
Functional ambulation | Modified 6 Minute Walk Test (M-6MWT) [60]; distance and fatigability index calculated by [the distance walked in the last minute ÷ distance walked in the first minute], with ratio ≥ 1.0 indicating less fatigability; Reliability high (ICC across 3 walks, 0.95). | |
Strength | Grip, vertical jump, push-ups, curl-ups [65] | ½ SD: jump 5cm; curl ups 5; push ups 3; grip strength 12 [46]. |
Fatigue symptoms | Unidimensional Fatigue Impact Scale [66]; which is a Rasch validated measure of fatigue modeled from the original and modified versions [60, 67] | Minimum clinically important difference(MCID) 5; ½ SD = 6 [66]. |
Mood* | Meaningful change: 10 | |
Global physical function* | Meaningful change = 10 | |
Health perception* | Meaningful change = 10 | |
Quality of life* | Meaningful change ½ SD = 12.5 | |
Explanatory Variables | ||
Current disability level | PDDS (patient version of EDSS) for all persons [76] | |
Relapses | Defined as “patient-reported or objectively observed events typical of an acute inflammatory demyelinating event in the CNS, current or historical, with duration of at least 24 hours, in the absence of fever or infection.” [47]; annualized rate over study period | |
Exercise adherence | Exercise diary (paper, computer version) daily for 3 months, 1 week every 3 months subsequently; accelerometers worn for 1 week every 3 months (see response to reviewers on feasibility of this) ActivPal [77] | |
Exercise self-efficacy | 3 item questionnaire with demonstrated validity and test-retest reliability (>0.85) [78] | |
Exercise barriers and benefits | The benefits subscale of the Exercise Benefits/Barriers Scale will be used [79] along with 4 indicators for barriers shown to be independent predictors of exercise engagement [21, 44] |